Search
for
Sort by
Research 181–210 of 1000+
- The Role of Janus Kinase Inhibitors in Dermatology
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Comparative Efficacy Evaluation of Alopecia Areata Management with Janus Kinase Inhibitors in Children: Retrospective Cohort Study
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Bisindolylmaleimide Protein-Kinase-C Inhibitors Delay the Decline in DNA Synthesis in Mouse Hair Follicle Organ Cultures
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- A review of Janus kinase inhibitor use in scarring alopecia
- Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- The Current State of Patient Adherence to Lab Monitoring Guidelines for Janus Kinase Inhibitors in Patients with Alopecia Areata.
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Janus kinase inhibitors for alopecia areata
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata